![Fred Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Fred Porter currently works at Taysha Gene Therapies, Inc., as Chief of Staff & Technical Operations Officer from 2020.
Dr. Porter also formerly worked at BridgeBio Pharma, Inc., as SVP-Technical Development & Manufacturing from 2018 to 2020.
Fred Porter active positions
| Companies | Position | Start |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Former positions of Fred Porter
| Companies | Position | End |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Corporate Officer/Principal | 2020-07-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
- Stock Market
- Insiders
- Fred Porter
